Table 1.
Characteristics of a national sample of parents of 11- to 17-year-old adolescents, 2014–2015 (N=1,501).
| N | % | |
|---|---|---|
| Household characteristics | ||
| Income | ||
| <$35,000 | 329 | 22 |
| $35,000 – $74,999 | 467 | 31 |
| ≥$75,000 | 705 | 47 |
| Region | ||
| Northeast | 261 | 17 |
| Midwest | 392 | 26 |
| South | 497 | 33 |
| West | 351 | 23 |
| Resident of state that requires HPV vaccination for school attendance |
43 | 3 |
| Child characteristics | ||
| Female | 738 | 49 |
| Age (years) | ||
| 11–12 | 420 | 28 |
| 13–17 | 1,081 | 72 |
| HPV vaccination status | ||
| 0 doses | 807 | 54 |
| ≥1 dose | 694 | 46 |
| Parents’ characteristics and attitudes about HPV vaccine | ||
| Female | 835 | 56 |
| Race/Ethnicity | ||
| Non-Hispanic White | 1,056 | 70 |
| Non-Hispanic Black | 134 | 9 |
| Hispanic | 212 | 14 |
| Other | 99 | 7 |
| Education | ||
| High school degree or less | 574 | 38 |
| Some college | 389 | 26 |
| Bachelor’s degree or higher | 538 | 36 |
| Psychological reactance | ||
| Low | 1,089 | 73 |
| High | 412 | 27 |
| Has a doctor or other health care provider ever told your child should get the HPV vaccine? |
||
| No | 721 | 48 |
| Yes | 780 | 52 |
| Relative importance of HPV vaccine compared to Tdap and meningococcal vaccines |
||
| Less important | 736 | 49 |
| As or more important | 765 | 51 |
| The HPV vaccine might cause lasting health problems. | ||
| Disagree/neither | 1,153 | 77 |
| Agree | 348 | 23 |
| The HPV vaccine is being pushed to make money for drug companies. |
||
| Disagree/neither | 1,022 | 68 |
| Agree | 479 | 32 |
| I don’t have enough information about the HPV vaccine to decide whether to give it to my child. |
||
| Disagree/neither | 1,022 | 68 |
| Agree | 479 | 32 |
| The HPV vaccine is effective in preventing cervical cancer. | ||
| Disagree/neither | 900 | 60 |
| Agree | 601 | 40 |
| It would be hard to find a provider or clinic where I can afford HPV vaccine for my child. |
||
| Disagree/neither | 1,419 | 94 |
| Agree | 82 | 6 |